Skip to main content
. 2017 Feb 14;2017:5473197. doi: 10.1155/2017/5473197

Figure 3.

Figure 3

Some of the key classes of genes that are observed to contribute to the development of malignancy. All are potential targets for therapy in leukaemia. Adapted from Murati et al. [27].